ALMKT:EPA
Mauna Kea Technologies SA
€ 0.092
0.00%
(0.00) Siku 1
13 Nov, 17:35:01 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.14M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
0.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.14M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
0.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
investingLive
·
saa 2 zilizopita
Morgan Stanley goes max overweight global stocks, sees 15% S&P 500 upside on AI capex
The Motley Fool
·
saa 10 zilizopita
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
siku 1 iliyopita
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
BigGo Finance
·
saa 15 zilizopita
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com